Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 3—March 2025
Research Letter

Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola

Ngiambudulu M. Francisco, Alberto Gaviraghi, Francesca Alladio, Ralph Huits, Bruna Carnielli, Elena Salvador, Giacomo Stroffolini, Niccolò Ronzoni, Paolo Cattaneo, Concetta Castilletti, Alberto Kalume, Cristina Mazzi, Alberto Matteelli, Dora Buonfrate, and Federico G. GobbiComments to Author 
Author affiliation: Instituto Nacional de Investigacao em Saude, Luanda, Angola (N.M. Francisco); IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy (A. Gaviraghi, F. Alladio, E. Salvador, G. Stroffolini, N. Ronzoni, P. Cattaneo, C. Castilletti, C. Mazzi, D. Buonfrate, F.G. Gobbi); IRCCS Sacro Cuore Don Calabria Hospital, Verona, Italy (R. Huits); Presidio Ospedale Santa Maria del Prato, Feltre, Italy (B. Carnielli); Hospital Divina Providencia, Luanda (A. Kalume); University of Brescia and Brescia Spedali Civili General Hospital WHO Collaborating Centre for TB/HIV and TB Elimination, Brescia, Italy (A. Matteelli); University of Brescia, Brescia (F.G. Gobbi)

Main Article

Table 2

Multivariable logistic regression models evaluating risk factors for RR and MDR TB, Luanda, Angola*

Characteristic RR TB
MDR TB
OR (95% CI) p value OR (95% CI) p value
Age
1 ((0.97–1.03)
0.8

1.02 ((0.98–1.06)
0.4
Sex
M Referent Referent
F
0.59 (0.27–1.25)
0.2

0.39 (0.13–1.07)
0.075
Body mass index
0.96 (0.84–1.08)
0.5

0.91 (0.75–1.07)
0.3
Smoking
N Referent Referent
Y
0.84 (0.22–2.63)
0.8

0.44 (0.02–2.85)
0.5
Alcohol
N Referent Referent
Y
1.01 (0.38–2.46)
>0.9

0.85 (0.18–3.01)
0.8
HIV
Negative Referent Referent
Positive 1.16 (0.26–3.76) 0.8 0.57 (0.03–3.23) 0.6

*MDR, multidrug-resistant; OR, odds ratio; RR, rifampin-resistant; TB, tuberculosis.

Main Article

Page created: February 04, 2025
Page updated: February 21, 2025
Page reviewed: February 21, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external